CEL-SCI Corp (CVM) Updates on November Enrollment Data for Ongoing Multikine Phase 3
Tweet Send to a Friend
CEL-SCI Corp (NYSE: CVM) announced that in the month of November it has enrolled 27 patients in its ongoing Phase ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
